Healthcare trends

Antibiotics Market: Increasing Efforts Undertaken by Major Companies for the Development of Advanced Antibiotic Products is Projected to Boost Market Growth at a Healthy CAGR of 4.8% During the Forecast Period of 2019 to 2025 : According to MRFR analysis,  Antibiotics Market  is expected to register a  CAGR of 4.8%  during the forecast period of  2019 to 2025  and was valued at  USD 51,835 Million in 2018. Antibiotics are powerful medicines that fight bacterial infections. They either stop bacteria from reproducing or destroy them. Several types of antibiotics are available, and they are generally available with a prescription in most countries. Segmentation The global  antibiotics market  has been segmented based on drug class, spectrum of activity, drug origin, and end user. The market, based on drug class, has been divided into cephalosporins, penicillin, fluoroquinolones, macrolides, carbapenem, aminoglycosides, sulfonamides, and others. ...

Industry Report “Antibiotics Market Research Report - Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.   Market Synopsis Supportive government legislations, such as the implementation of the Generating Antibiotics Incentives Now (GAIN) Act in the US, are expected to accelerate the drug approval process in the  antibiotics market. Key Players Some of the key players in the Global Antibiotics Market are Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Astellas Pharma Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), Abbott Laboratories (US), GlaxoSmithKline PLC (UK), Sanofi (France), Bayer AG (Germany), Eli Lilly and Company (US), and Merck & Co., Inc. (US). S...